These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37686317)

  • 1. Macrophage-Myofibroblast Transition Contributes to Myofibroblast Formation in Proliferative Vitreoretinal Disorders.
    Abu El-Asrar AM; De Hertogh G; Allegaert E; Nawaz MI; Abouelasrar Salama S; Gikandi PW; Opdenakker G; Struyf S
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT).
    Abu El-Asrar AM; De Hertogh G; van den Eynde K; Alam K; Van Raemdonck K; Opdenakker G; Van Damme J; Geboes K; Struyf S
    Exp Eye Res; 2015 Mar; 132():179-89. PubMed ID: 25637870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proprotein convertase furin is a driver and potential therapeutic target in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ahmad A; Siddiquei MM; Allegaert E; Gikandi PW; De Hertogh G; Opdenakker G
    Clin Exp Ophthalmol; 2022 Aug; 50(6):632-652. PubMed ID: 35322530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ahmad A; Siddiquei MM; Allegaert E; Gikandi PW; De Hertogh G; Opdenakker G
    Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):32. PubMed ID: 34293080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-Depth Molecular Characterization of Neovascular Membranes Suggests a Role for Hyalocyte-to-Myofibroblast Transdifferentiation in Proliferative Diabetic Retinopathy.
    Boneva SK; Wolf J; Hajdú RI; Prinz G; Salié H; Schlecht A; Killmer S; Laich Y; Faatz H; Lommatzsch A; Busch M; Bucher F; Stahl A; Böhringer D; Bengsch B; Schlunck G; Agostini H; Lange CAK
    Front Immunol; 2021; 12():757607. PubMed ID: 34795670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-1 studies in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Allegaert E; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2020 Feb; 98(1):e1-e12. PubMed ID: 31318490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Expression and Localization of ADAMTS Proteinases in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Nawaz MI; Allegaert E; Siddiquei MM; Ahmad A; Gikandi P; De Hertogh G; Opdenakker G
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage to myofibroblast transition contributes to subretinal fibrosis secondary to neovascular age-related macular degeneration.
    Little K; Llorián-Salvador M; Tang M; Du X; Marry S; Chen M; Xu H
    J Neuroinflammation; 2020 Nov; 17(1):355. PubMed ID: 33239022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of myofibroblast activation molecules in proliferative vitreoretinopathy epiretinal membranes.
    Abu El-Asrar AM; Missotten L; Geboes K
    Acta Ophthalmol; 2011 Mar; 89(2):e115-21. PubMed ID: 20528783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 Ligand-CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ahmad A; Dillemans L; Siddiquei M; Allegaert E; Gikandi PW; De Hertogh G; Opdenakker G; Struyf S
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders.
    Abu El-Asrar AM; Van den Steen PE; Al-Amro SA; Missotten L; Opdenakker G; Geboes K
    Int Ophthalmol; 2007 Feb; 27(1):11-22. PubMed ID: 17375263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy.
    Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Alam K; Siddiquei MM; Van den Eynde K; Mousa A; Mohammad G; Geboes K; Opdenakker G
    Mol Vis; 2014; 20():1209-24. PubMed ID: 25253987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
    Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
    Armstrong D; Augustin AJ; Spengler R; Al-Jada A; Nickola T; Grus F; Koch F
    Ophthalmologica; 1998; 212(6):410-4. PubMed ID: 9787233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of autotaxin and acylglycerol kinase in proliferative vitreoretinal epiretinal membranes.
    Abu El-Asrar AM; Missotten L; Geboes K
    Acta Ophthalmol; 2012 Mar; 90(2):e84-9. PubMed ID: 22103573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation.
    Yoshida S; Kobayashi Y; Nakama T; Zhou Y; Ishikawa K; Arita R; Nakao S; Miyazaki M; Sassa Y; Oshima Y; Izuhara K; Kono T; Ishibashi T
    Br J Ophthalmol; 2015 May; 99(5):629-34. PubMed ID: 25355804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
    Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
    Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.